Sort by
Keyphrases
Chronic Spontaneous Urticaria
78%
Chronic Urticaria
59%
Clinical Features
48%
Urticaria Control Test
41%
Treatment Response
40%
Omalizumab
36%
Symptomatic Dermographism
25%
Antihistamines
24%
Omalizumab Treatment
24%
Rare Disease Diagnosis
21%
Angioedema
21%
Quality of Life
19%
H1-antihistamines
18%
Dermatology Life Quality Index
16%
Urticaria
15%
Disease Activity Score
15%
Pruritus
13%
Laboratory Features
13%
Turkish Version
13%
Systemic Disease
13%
Prospective Controlled Study
13%
Comorbidity
12%
Etiological Factors
11%
Mast Cells
11%
Comorbid Conditions
11%
Test Correlation
10%
Systemic Isotretinoin
10%
Leg Ulcer
10%
Vaccination
10%
Cell-mediated
10%
Antecubital Fossa
10%
New Scoring System
10%
Predominant Subtype
10%
Depression Score
10%
Depressive Symptoms
10%
Change Score
10%
Ovarian Reserve
10%
Bradykinin
10%
Menstrual Irregularities
10%
Unveiling
10%
Turkish Patients
10%
COVID-19
10%
Vitiligo
10%
Granular Cell Tumor
10%
Follicle-stimulating Hormone
10%
Antiphospholipid Syndrome
10%
Female Patients
10%
Predictors of Treatment Response
10%
Sociodemographic Characteristics
10%
Comparative Analysis
10%
Medicine and Dentistry
Urticaria
100%
Chronic Urticaria
96%
Treatment Response
49%
Omalizumab
35%
Histamine Antagonist
27%
Dermographism
27%
Clinical Feature
24%
Pruritus
16%
Angioedema
16%
Comorbidity
15%
Disease Activity
13%
Dermatology Life Quality Index
13%
Mast Cell
12%
Vitiligo
10%
Scoring System
10%
COVID-19
10%
Granular Cell Tumor
10%
Bradykinin
10%
Leg Ulcer
10%
Antiphospholipid Syndrome
10%
Depressive Disorder
9%
Disease Duration
7%
Virus Vaccine
5%
Prevalence
5%
Beck Depression Inventory
5%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Urticaria
65%
Urticaria
47%
Omalizumab
43%
Antihistaminic Agent
23%
Angioneurotic Edema
18%
Clinical Feature
13%
Disease Activity
12%
Dermographism
10%
Ciclosporin
10%
Bradykinin
10%
Isotretinoin
10%
Vitiligo
10%
Follitropin
10%
Muellerian Inhibiting Factor
10%
Menstrual Irregularity
10%
Depressive Disorder
8%
Disease Duration
5%
Virus Vaccine
5%